SCRT, Chemo, Immuno-neoadjuvant Therapy, Rectal Adenocarcinoma, Guangzhou, Phase III
Summary
A Phase III clinical trial investigating short-course radiotherapy (SCRT) combined with chemotherapy and immuno-neoadjuvant therapy for rectal adenocarcinoma is registered on ClinicalTrials.gov under NCT07549399. The trial is being conducted in Guangzhou, China, and is currently listed in the ClinicalTrials.gov Phase III registry sorted by start date. No specific enrollment, completion dates, or regulatory compliance details are provided in this database entry.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.
What changed
This entry records a Phase III clinical trial on ClinicalTrials.gov investigating SCRT (short-course radiotherapy) combined with chemotherapy and immuno-neoadjuvant therapy for rectal adenocarcinoma in Guangzhou, China. The trial is registered under NCT07549399. Clinical trial registrations on ClinicalTrials.gov are informational entries that do not impose compliance obligations. Healthcare institutions, clinical investigators, and pharmaceutical sponsors may reference this registry for awareness of ongoing research in this therapeutic area.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.